Last $25.58 USD
Change Today +0.31 / 1.23%
Volume 73.0K
SGNT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mary Taylor Behrens

Director, Chairperson of Compensation Committee and Member of Corporate Governance & Nominating Committee, Sagent Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships
53$128,492

Background*

Ms. Mary Taylor Behrens served as the President of Newfane Advisors, Inc since November 2004. Ms. Behrens has particular knowledge and experience in human resources, strategic planning and leadership of complex organizations. She formed Newfane Advisors after 13 years as a Senior Executive with Merrill Lynch & Co., Inc. with responsibilities that included serving as the Head of Human Resources and Head, Americas Region of Merrill Lynch Investment Managers. From February ...

Read Full Background

Corporate Headquarters*

1901 North Roselle Road
Schaumburg, Illinois 60195

United States

Phone: 847-908-1600
Fax: 847-908-1601

Board Members Memberships*

2004-Present
Director, Member of Compensation Committee and Member of Quality Committee
2010-Present
Director, Chairperson of Compensation Committee and Member of Corporate Governance & Nominating Committee
2013-2014
Former Director

Education*

BA
Georgetown University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$78,500
Total Calculated Compensation$128,492
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGNT:US $25.58 USD +0.31

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
$563.4K
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Aijaz Tobaccowalla Managing Director, Additional Director, Member of Board Administrative Committee and Member of Nomination & Remuneration Committee
Pfizer Limited
30.3M
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGENT PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.